YINGCHI TMS has received new FDA granted clearances for two major treatment indications

We are thrilled to announce that YINGCHI TMS has received new FDA granted clearances for two major treatment indications: ✔ YINGCHI rTMS for Obsessive-Compulsive Disorder (OCD) – K243459   ✔ Intermittent Theta Burst Stimulation (iTBS) for Major Depressive Disorder – K243460 So far, YINGCHI TMS has been approved by FDA for rTMS treating OCD, rTMS treating MDD,... Read more

Xiao, J., Ming, Y., Li, L., Huang, X., Zhou, Y., Ou, J., Kou, J., Feng, R., Ma, R., Zheng, Q., Shan, X., Meng, Y., Liao, W., Zhang, Y., Wang, T., Kuang, Y., Cao, J., Li, S., Lai, H., Chen, J., … Duan, X. (2025). Personalized Theta Burst Stimulation Enhances Social Skills in Young Minimally Verbal Children With Autism: A Double-Blind Randomized Controlled Trial. Biological psychiatry, S0006-3223(25)00024-1. Advance online publication. https://doi.org/10.1016/j.biopsych.2025.01.002

YINGCHI Technology